532 related articles for article (PubMed ID: 17030273)
1. Extent of surgical resection for esophageal and gastroesophageal junction adenocarcinomas.
Vrouenraets BC; van Lanschot JJ
Surg Oncol Clin N Am; 2006 Oct; 15(4):781-91. PubMed ID: 17030273
[TBL] [Abstract][Full Text] [Related]
2. Classification, diagnosis and surgical treatment of carcinomas of the gastroesophageal junction.
Mönig SP; Schröder W; Beckurts KT; Hölscher AH
Hepatogastroenterology; 2001; 48(41):1231-7. PubMed ID: 11677937
[TBL] [Abstract][Full Text] [Related]
3. New insights in the lymphatic spread of oesophageal cancer and its implications for the extent of surgical resection.
Cense HA; van Eijck CH; Tilanus HW
Best Pract Res Clin Gastroenterol; 2006; 20(5):893-906. PubMed ID: 16997168
[TBL] [Abstract][Full Text] [Related]
4. Topographical distribution of lymph node metastasis in adenocarcinoma of the gastroesophageal junction.
Mönig SP; Baldus SE; Zirbes TK; Collet PH; Schröder W; Schneider PM; Dienes HP; Hölscher AH
Hepatogastroenterology; 2002; 49(44):419-22. PubMed ID: 11995464
[TBL] [Abstract][Full Text] [Related]
5. Adenocarcinoma of the gastroesophageal junction: benefits of an extended lymphadenectomy.
Williams VA; Peters JH
Surg Oncol Clin N Am; 2006 Oct; 15(4):765-80. PubMed ID: 17030272
[TBL] [Abstract][Full Text] [Related]
6. Reflections on three field lymphadenectomy in carcinoma of the esophagus and gastroesophageal junction.
Lerut T; Coosemans W; De Leyn P; Deneffe G; Topal B; Van de Ven C; Van Raemdonck D
Hepatogastroenterology; 1999; 46(26):717-25. PubMed ID: 10370600
[TBL] [Abstract][Full Text] [Related]
7. Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients.
Feith M; Stein HJ; Siewert JR
Surg Oncol Clin N Am; 2006 Oct; 15(4):751-64. PubMed ID: 17030271
[TBL] [Abstract][Full Text] [Related]
8. Individualized surgical strategies for cancer of the esophagogastric junction.
Stein HJ; Feith M; Siewert JR
Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787
[TBL] [Abstract][Full Text] [Related]
9. Current trends in the surgical treatment of esophageal and cardia adenocarcinoma.
Peracchia A; Bonavina L; Via A; Incarbone R
J Exp Clin Cancer Res; 1999 Sep; 18(3):289-94. PubMed ID: 10606171
[TBL] [Abstract][Full Text] [Related]
10. [Limited surgical resection versus local endoscopic therapy of early cancers of the esophagogastric junction].
von Rahden BH; Feith M; Stein HJ
Zentralbl Chir; 2006 Apr; 131(2):97-104. PubMed ID: 16612774
[TBL] [Abstract][Full Text] [Related]
11. Clinical impact of endoscopic submucosal dissection for superficial adenocarcinoma located at the esophagogastric junction.
Yoshinaga S; Gotoda T; Kusano C; Oda I; Nakamura K; Takayanagi R
Gastrointest Endosc; 2008 Feb; 67(2):202-9. PubMed ID: 18226681
[TBL] [Abstract][Full Text] [Related]
12. Extended surgery for cancer of the esophagus and gastroesophageal junction.
Lerut T; Coosemans W; Decker G; De Leyn P; Moons J; Nafteux P; Van Raemdonck D
J Surg Res; 2004 Mar; 117(1):58-63. PubMed ID: 15013715
[TBL] [Abstract][Full Text] [Related]
13. Clinical biology and surgical therapy of intramucosal adenocarcinoma of the esophagus.
Oh DS; Hagen JA; Chandrasoma PT; Dunst CM; Demeester SR; Alavi M; Bremner CG; Lipham J; Rizzetto C; Cote R; Demeester TR
J Am Coll Surg; 2006 Aug; 203(2):152-61. PubMed ID: 16864027
[TBL] [Abstract][Full Text] [Related]
14. Surgery for early stage esophageal adenocarcinoma.
Stein HJ; von Rahden BH; Feith M
J Surg Oncol; 2005 Dec; 92(3):210-7. PubMed ID: 16299789
[TBL] [Abstract][Full Text] [Related]
15. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction].
Schmidt SC; Schlechtweg N; Veltzke-Schlieker W; Thuss-Patience P; Pratschke J; Neuhaus P; Schumacher G
Zentralbl Chir; 2009 Sep; 134(5):455-61. PubMed ID: 19757346
[TBL] [Abstract][Full Text] [Related]
16. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial.
Omloo JM; Lagarde SM; Hulscher JB; Reitsma JB; Fockens P; van Dekken H; Ten Kate FJ; Obertop H; Tilanus HW; van Lanschot JJ
Ann Surg; 2007 Dec; 246(6):992-1000; discussion 1000-1. PubMed ID: 18043101
[TBL] [Abstract][Full Text] [Related]
17. High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas.
Bollschweiler E; Baldus SE; Schröder W; Prenzel K; Gutschow C; Schneider PM; Hölscher AH
Endoscopy; 2006 Feb; 38(2):149-56. PubMed ID: 16479422
[TBL] [Abstract][Full Text] [Related]
18. Lymph node analysis in esophageal resection: American College of Surgeons Oncology Group Z0060 trial.
Veeramachaneni NK; Zoole JB; Decker PA; Putnam JB; Meyers BF;
Ann Thorac Surg; 2008 Aug; 86(2):418-21; discussion 421. PubMed ID: 18640307
[TBL] [Abstract][Full Text] [Related]
19. Prediction of lymph node status in superficial esophageal carcinoma.
Ancona E; Rampado S; Cassaro M; Battaglia G; Ruol A; Castoro C; Portale G; Cavallin F; Rugge M
Ann Surg Oncol; 2008 Nov; 15(11):3278-88. PubMed ID: 18726651
[TBL] [Abstract][Full Text] [Related]
20. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome.
Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
Ann Surg Oncol; 2007 Feb; 14(2):306-16. PubMed ID: 17091329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]